Orasure Technologies, Inc balance sheet OSUR

Annual Quarterly

As of Jun 30, 2026, Orasure Technologies, Inc had total assets of $360.6 million and total liabilities of $42.8 million. Total assets were down 19.0% from a year earlier. Stockholders' equity was $317.8 million. It held $160.6 million in cash and investments against $12.1 million of total debt, net cash of $148.5 million. The current ratio, current assets divided by current liabilities, was 8.88.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the same quarter a year earlier.

Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Q3 FY2024
Sep 30, 2024
Assets
Cash
161
-31.5%
177
-28.5%
199
-25.6%
216
-22.3%
235
-9.2%
248
+0.2%
268
-7.8%
279
+28.1%
Cash and investments
161
-31.5%
177
-28.5%
199
-25.6%
216
-22.3%
235
-12.3%
248
-6.1%
268
-7.8%
279
+23.9%
Receivables
26
-1.2%
25
+15.3%
22
-6.8%
24
-9.8%
26
-32.0%
22
-36.8%
24
-40.7%
27
-49.5%
Inventory
30
-9.9%
30
-15.1%
31
-9.2%
33
-14.1%
33
-12.8%
36
-17.4%
34
-28.2%
39
-34.4%
Total current assets
223
-26.0%
241
-23.3%
262
-21.4%
283
-19.2%
301
-14.1%
314
-10.0%
333
-13.8%
350
-1.8%
Property and equipment, net
39
-8.5%
38
-12.3%
39
-13.1%
41
+7.0%
42
+4.6%
43
+1.3%
45
-0.7%
38
-20.6%
Goodwill
43
+2.3%
43
+6.4%
43
+7.5%
41
+17.1%
42
+19.4%
40
+15.0%
40
+13.0%
35
+0.7%
Total assets
361
-19.0%
379
-17.1%
403
-15.9%
423
-8.8%
445
-4.6%
458
-2.1%
480
-0.7%
464
+1.2%
Liabilities and equity
Accounts payable
8
+31.7%
11
+35.9%
7
-20.2%
6
-33.6%
6
-29.8%
8
-38.3%
8
-37.9%
10
-36.0%
Total current liabilities
25
-40.7%
44
+73.4%
40
+18.9%
40
+44.9%
42
+46.8%
25
-12.7%
33
-15.3%
28
-32.1%
Total liabilities
43
-33.5%
66
+7.4%
62
-10.1%
61
+58.7%
64
+58.8%
61
+48.5%
69
+32.9%
39
-28.1%
Stockholders' equity
318
-16.5%
313
-20.9%
341
-16.9%
362
-14.9%
381
-10.6%
396
-7.0%
410
-4.7%
426
+5.1%
Debt
Lease liabilities
12
-14.4%
13
-10.9%
13
-9.6%
13
+21.2%
14
+11.9%
14
+9.3%
15
+8.1%
11
-26.1%
Total debt
12
-14.4%
13
-10.9%
13
-9.6%
13
+21.2%
14
+11.9%
14
+9.3%
15
+8.1%
11
-26.1%
Net cash
148
-32.6%
164
-29.6%
186
-26.5%
203
-24.1%
220
-13.5%
233
-6.9%
253
-8.6%
267
+27.4%
Ratios
Current ratio
8.88x
5.46x
6.58x
7.03x
7.12x
12.34x
9.95x
12.60x
Debt to equity
0.04x
0.04x
0.04x
0.04x
0.04x
0.04x
0.04x
0.03x
Debt to EBITDA
—
—
—
—
—
—
—
1,110.70x
Return on equity
-15.46%
-23.96%
-20.17%
-16.64%
-13.40%
-8.06%
-4.75%
2.67%
Return on assets
-13.63%
-19.80%
-17.05%
-14.24%
-11.47%
-6.98%
-4.07%
2.45%
Book value per share
4.61
4.51
4.84
5.01
5.16
5.28
5.50
5.71
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
OSUR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bethlehem, PA
SEC filer status
Accelerated filer
SEC CIK
1116463

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.